# Niagara Pharmaceuticals Inc – FDA Inspection, Feb 7, 2020

Source: https://www.keypedia.com/records/fda_inspections/niagara-pharmaceuticals-inc/dbc973f2-edee-4f9c-a795-0718e8a091a2
Source feed: FDA_Inspections

> FDA inspection 1117142 of Niagara Pharmaceuticals Inc, February 07, 2020. Classification: Official Action Indicated (OAI). 2 citations under 21 CFR part 211. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1117142
- Company Name: Niagara Pharmaceuticals Inc
- Inspection Date: 2020-02-07
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 1167881 - 2022-04-25](https://www.keypedia.com/records/fda_inspections/niagara-pharmaceuticals-inc/ab045d3c-45f7-4c1d-86c2-6d21f4cb8a72)
- [FDA Inspection 1031416 - 2017-09-18](https://www.keypedia.com/records/fda_inspections/niagara-pharmaceuticals-inc/66c14af1-385f-46bf-b8c7-860b8a30d1db)
- [FDA Inspection 975165 - 2016-05-16](https://www.keypedia.com/records/fda_inspections/niagara-pharmaceuticals-inc/f61269f4-f899-41b8-af60-b152cb8fdc24)
- FDA Inspection 883362 - 2014-05-14
- [FDA Inspection 694739 - 2010-09-08](https://www.keypedia.com/records/fda_inspections/niagara-pharmaceuticals-inc/1be4e2a6-0c70-4f4d-a97c-44bc12d6cab5)

Company: https://www.keypedia.com/companies/niagara-pharmaceuticals-inc/86d1fc76-da98-4df3-bf23-bed8075fdd53

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
